6 results
Antiphospholipid Syndrome (APS)
APS is a rare autoimmune disorder characterized by recurring blood clots resulting from antibodies
Syndrome (APS) ... to be present Treatment ... (EULAR Guidelines ... #Syndrome #APS ... #guidelines
2019 EULAR recommendations for thrombosis in (Antiphospholipid Syndrome) APS
Venous Thrombosis - Arterial Thrombosis
INR Target
Duration
Recurrence

Dr. Laurent ARNAUD
Syndrome) APS ... Venous Thrombosis - Arterial ... #Syndrome #APS ... management #EULAR2019 #guidelines ... rheumatology #hematology #treatment
Xa Inhibitors - Apixaban and Rivaroxaban 
Oral Xa inhibitors are recommended by CHEST as first-line for
patients with VTE treatment ... or Atrial Fibrillation ... requiring anticoagulation ... Rivaroxaban #Dosing #Pharmacology
Low-dose aspirin and low-molecular-weight heparin in lupus and Antiphospholipid Syndrome (APS) pregnancy

• No previous history of
Syndrome (APS) ... thrombotic APS (arterial ... #Syndrome #APS ... pregnancy #Obstetrics #Anticoagulation ... #LWMH #Dosing #Pharmacology
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Clinical Practice Guideline ... compared the study treatment ... with ‘treatment ... 5.2 and 5.4 #EBM ... #Management #Pharmacology
Probiotics Guidelines
Adults with C difficile infection
 • Recommendation: Only in the context of a clinical trial
Probiotics Guidelines ... on antibiotic treatment ... irritable bowel syndrome ... #Probiotics #Guidelines ... management #evidence #ebm